Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Grant Benham
Observed name:
G. Benham
Institutions:
Brigham and Women's Hospital,
Dana-Farber Cancer Institute,
Dana-Farber Brigham Cancer Center
Observed institutions:
Brigham and Women's Hospital,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber Brigham Cancer Center,
Mass General Brigham
OpenAlex ID:
A5117728606
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation
2026
·
Ayal A. Aizer
, Kee-Young Shin
, et al.
·
JAMA
·
40
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
2025
·
Ayal A. Aizer
, Shyam K. Tanguturi
, et al.
·
Journal of Clinical Oncology
·
23
Stereotactic radiation versus hippocampal avoidance whole brain radiation in patients with 5-20 brain metastases: A multicenter, phase 3 randomized trial.
2025
·
Ayal Aizer
, Shyam Kumar Tanguturi
, et al.
·
Journal of Clinical Oncology
·
23
Multicenter, Phase 3 Randomized Trial of Stereotactic Radiation vs. Hippocampal Avoidance Whole Brain Radiation in Patients with 5-20 Brain Metastases: Recurrence, Salvage Therapy, and Mortality Endpoints
2025
·
A.A. Aizer
, S. Tanguturi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Four-Year Feasibility and Safety Results of a Phase 1/2 Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases
2026
·
Thomas P. Howard
, Tyler Walburn
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
NCOG-20. Stereotactic radiation versus hippocampal avoidant whole brain radiation in patients with 5-20 brain metastases: Cognitive outcomes of 12-month survivors
2025
·
Michael Parsons
, Kee-Young Shin
, et al.
·
Neuro-Oncology
PDF
Four-Year Results of a Phase I/II Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases
2025
·
T. Howard
, G. Benham
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Feasibility of 3 Fraction Treatment Using Stereotactic Magnetic Resonance – Guided Adaptive Radiation Therapy in Single or Three Fractions for Oligometastases in the Abdomen and Pelvis: Results from the Phase I SMART-STOP 3-Fraction Cohort
2025
·
Z.L. Cosner
, Y.H. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Stereotactic magnetic resonance imaging-guided adaptive radiotherapy: a pooled analysis of a master prospective trial
2025
·
Jonathan E Leeman
, Kee-Young Shin
, et al.
·
JNCI Journal of the National Cancer Institute
Show more works
View as search
Works count:
9
Citation count:
88
H-index:
3
I10-index:
3
Year
Topic
Type